Brewin Dolphin Wealth Management LTD Repligen Corp Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Repligen Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 113 shares of RGEN stock, worth $17,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 113
-0.0%
Holding current value
$17,869
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.2 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.01 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$798 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$257 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$225 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.78B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....